Showing results (161-170 of 180) with videos related to

Sort By:
Pageof 18
Frontiers in Human Neuroscience|August 2, 2021
Determination of Dynamic Brain Connectivity via Spectral AnalysisPeter A Robinson, James A Henderson, Natasha C Gabay, et al.
Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation|February 15, 2001
Can a nutrition intervention improve albumin levels among hemodialysis patients? A pilot studyJ B Leon, A D Majerle, J A Soinski, et al.
The Journal of Rheumatology. Supplement|January 1, 1977
HLA B27 in ankylosing spondylitis: differences in frequency and relative risk in American Blacks and CaucasiansM A Khan, W E Braun, I Kushner, et al.
Clinical and Experimental Immunology|August 1, 1996
Circulating levels of IL-11 and leukaemia inhibitory factor (LIF) do not significantly participate in the production of acute-phase proteins by the liverC Gabay, M Singwe, B Genin, et al.
The Journal of Rheumatology|January 1, 2023
HLA B27 in Ankylosing Spondylitis: Differences in Frequency and Relative Risk in American Blacks and CaucasiansM A Khan, W E Braun, I Kushner, et al.
Journal of the American Veterinary Medical Association|August 5, 2009
Incidence of and risk factors for postoperative pneumonia in dogs anesthetized for diagnosis or treatment of intervertebral disk diseaseMelissa A Java, Kenneth J Drobatz, Robert S Gilley, et al.
Pediatrics|August 2, 2000
Kawasaki disease: A brief historyJ C Burns, H I Kushner, J F Bastian, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1988
Heterogeneous nature of the acute phase response. Differential regulation of human serum amyloid A, C-reactive protein, and other acute phase proteins by cytokines in Hep 3B cellsM K Ganapathi, D Schultz, A Mackiewicz, et al.
Arthritis and Rheumatism|March 7, 2001
Increased production of intracellular interleukin-1 receptor antagonist type I in the synovium of mice with collagen-induced arthritis: a possible role in the resolution of arthritisC Gabay, L Marinova-Mutafchieva, R O Williams, et al.
Annals of the Rheumatic Diseases|May 7, 2009
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?A Finckh, A Ciurea, L Brulhart, et al.
Pageof 18